Td Asset Management Inc Ac Immune Sa Transaction History

Td Asset Management Inc

  • $107 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
SELL
$4.83 - $7.56 $139,587 - $218,484
-28,900 Closed
0 $0
Q3 2021

Nov 09, 2021
BUY
$6.2 - $8.34 $179,180 - $241,026
28,900 New
28,900 $194,000
Q1 2019

May 08, 2019
SELL
$3.65 - $11.68 $63,896 - $204,470
-17,506 Closed
0 $0
Q3 2018

Nov 01, 2018
BUY
$7.88 - $16.45 $137,947 - $287,973
17,506 New
17,506 $140,000

Others Institutions Holding ACIU

# of Institutions
48
Shares Held
27.9M
Call Options Held
150K
Put Options Held
12.4K
View Full List

About AC Immune SA

ACIU Quotes by TradingView
  • Ticker ACIU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,413,504
  • Market Cap $220M
  • Description
  • AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...
More about ACIU
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email